Amphastar製藥 AMPH 深 滬
已收盤 08-01 16:00:00 美东时间
21.21
+0.260
+1.24%
華盛通- 最 高21.25
- 今 開20.86
- 成交量 44.02万股
- 最 低 20.385
- 昨 收 20.95
- 總市值 10.00亿
- 52周最高 53.955
- 市盈率 靜 6.92
- 換手率 0.93%
- 52周最低 20.385
- 委 比 -82.06%
- 總股本 4713.91万
- 歷史最高 67.66
- 量 比 1.10
- 振 幅 4.13%
- 歷史最低 6.67
- 每 手 1
- 風險率 10.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
Amneal Pharmaceuticals subsidiary seeks $1.8 billion in seven-year term loans and offers $750 million in senior secured notes due 2032. Proceeds will refinance existing term loans, repay ABL facility amounts, and cover related costs. The notes are secured by same assets as the term loans, with first-priority lien on collateral (excluding ABL priority collateral). The offering is for qualified institutional buyers and non-U.S. persons. The transac...
07-21 11:39
美股大行评级 | 潜在涨幅455.56%！Medicus Pharma获D. Boral Capital升目标价至27美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1128971739548127232.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• D. Boral Capital：维持Medicus Pharma(MDCX)"买入"评级，目标价从14美元升至27美元</p> <p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从
05-13 08:50
This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
05-12 21:26
Wells Fargo Maintains Overweight on Amphastar Pharma, Lowers Price Target to $35
Wells Fargo analyst Cerena Chen maintains Amphastar Pharma (NASDAQ:AMPH) with a Overweight and lowers the price target from $40 to $35.
05-08 21:21
Earnings Scheduled For May 7, 2025
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
Earnings Outlook For Amphastar Pharma
Amphastar Pharma (NASDAQ:AMPH) is gearing up to announce its quarterly earnings...
05-06 23:04
美股大行评级 | 高盛：上调Adaptive Biotechnologies评级至"买入"，目标价从8美元升至9美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1110125309827231744.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Amprius Technologies(AMPX)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 韦德布什：维持Monte Rosa Therapeutics(GLUE)"跑
03-24 07:31
Amphastar Pharma Q4 2024 Adj. EPS $0.92 Misses $0.94 Estimate, Sales $186.500M Miss $188.810M Estimate
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $0.94 by 2.13 percent. This is a 4.55 percent increase over earnings of $0.88 per share from
02-28 05:11
Earnings Scheduled For February 27, 2025
Companies Reporting Before The Bell • Hafnia (NYSE:HAFN) is estimated to report...
02-27 16:32
Top 2 Health Care Stocks That May Rocket Higher This Month
The most oversold stocks in the health care sector presents an opportunity to b...
02-22 03:17
